Smoking and polymorphisms of genes encoding mannose-binding lectin and surfactant protein-D in patients with rheumatoid arthritis

Rheumatology International

Volumn 34, Issue 3, 2014, Pages 373-380

  Kristiansen, Malthe ^a   Frisch, Morten ^b   Madsen, Hans Ole ^c   Garred, Peter ^c   Jacobsen, Søren ^a  

^a University of Copenhagen   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c Mental Health Center Glostrup   (Denmark)

Author keywords

Innate immunity; Mannose binding lectin; Pathogenesis; Rheumatoid arthritis; Smoking; Surfactant protein D

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; MANNOSE BINDING LECTIN; SURFACTANT PROTEIN D;

ADULT; AGED; ARTHROPATHY; ARTICLE; BONE EROSION; CASE CONTROL STUDY; CODON; DNA POLYMORPHISM; FEMALE; GENE; GENETIC CODE; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SMOKING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; EPITOPES; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; PEPTIDES, CYCLIC; POLYMORPHISM, GENETIC; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 84896723327     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2904-z     Document Type: Article

References (49)

1. Lindqvist E, Jonsson K, Saxne T, Eberhardt K (2003) Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Ann Rheum Dis 62:611-616
2. Jansen LM, van Schaardenburg D, van der Horst-Bruinsma I, van der Stadt RJ, de Koning MH, Dijkmans BA (2003) The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis. J Rheumatol 30:1691-1695
3. Klareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, Grunewald J et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthr Rheum 54:38-46
4. Hansen S, Holm D, Moeller V, Vitved L, Bendixen C, Reid KB et al (2002) CL-46, a novel collectin highly expressed in bovine thymus and liver. J Immunol 169:5726-5734
5. Garred P, Larsen F, Madsen HO, Koch C (2003) Mannose-binding lectin deficiency-revisited. Mol Immunol 40:73-84
6. Graudal NA, Madsen HO, Tarp U, Svejgaard A, Jurik G, Graudal HK, Garred P (2000) The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthr Rheum 43:515-521
7. Jacobsen S, Madsen HO, Klarlund M, Jensen T, Skjødt H, Jensen KE et al (2001) The influence of mannose binding lectin polymorphisms on disease outcome in early polyarthritis TIRA Group. J Rheumatol 28:935-942
8. Barton A, Platt H, Salway F, Symmons D, Lunt M, Worthington J, Silman A (2004) Polymorphisms in the mannose binding lectin (MBL) gene are not associated with radiographic erosions in rheumatoid or inflammatory polyarthritis. J Rheumatol 31:442-447
9. Saevarsdottir S, Steinsson K, Grondal G, Valdimarsson H (2007) Patients with rheumatoid arthritis have higher levels of mannan-binding lectin than their first-degree relatives and unrelated controls. J Rheumatol 34:1692-1695
10. Troelsen LN, Garred P, Madsen HO, Jacobsen S (2007) Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis. Arthr Rheum 56:21-29
11. Gupta B, Agrawal C, Raghav SK, Das SK, Das RH, Chaturvedi VP, Das HR (2005) Association of mannose-binding lectin gene (MBL2) polymorphisms with rheumatoid arthritis in an Indian cohort of case-control samples. J Hum Genet 50:583-591
12. Jacobsen S, Garred P, Madsen HO, Heegaard NH, Hetland ML, Stengaard-Pedersen K et al (2009) Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis. J Rheumatol 36:731-735
13. Leth-Larsen R, Garred P, Jensenius H, Meschi J, Hartshorn K, Madsen J et al (2005) A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol 174:1532-1538
14. Lin KW, Jen KY, Suarez CJ, Crouch EC, Perkins DL, Finn PW (2010) Surfactant protein D-mediated decrease of allergen-induced inflammation is dependent upon CTLA4. J Immunol 184:6343-6349
15. Christensen AF, Sørensen GL, Hørslev-Petersen K, Holmskov U, Lindegaard HM, Junker K et al (2010) Circulating surfactant protein-D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritis. Arthr Res Ther 12:R39
16. Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfahrt J, Frisch M (2006) Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthr Res Ther 8:R133
17. Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, Pedersen BV, Wohlfahrt J, Frisch M (2007) Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis. A nationwide case-control study in Denmark. Arthr Rheum 56:1446-1453
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315-324
19. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, Svejgaard A (1995) Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155:3013-3020
20. Leth-Larsen R, Garred P, Jensenius H, Meschi J, Hartshorn K, Madsen J et al (2005) A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol 174:1532-1538
21. Kimura A, Sasazuki T. HLA 1991. Oxford University Press; 1992
22. Knipper AJ, Hakenberg P, Enczmann J, Kuhröber A, Kiesel U, Kögler G, Wernet P (2000) HLA-DRB1,3,4,5 and -DQB1 allele frequencies and HLA-DR/DQ linkage disequilibrium of 231 German caucasoid patients and their corresponding 821 potential unrelated stem cell transplants. Hum Immunol 61:605-614
23. Høier-Madsen M, Nielsen LP, Møller S (1986) Determination of IgM rheumatoid factors by enzyme-linked immunosorbent assay (ELISA). Ugeskr Laeger 148:2018-2021
24. Graudal NA, Homann C, Madsen HO, Svejgaard A, Jurik AG, Graudal HK, Garred P (1998) Mannan binding lectin in rheumatoid arthritis. A longitudinal study. J Rheumatol 25:629-635
25. Saevarsdottir S, Vikingsdottir T, Vikingsson A, Manfredsdottir V, Geirsson AJ, Valdimarsson H (2001) Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study. J Rheumatol 28:728-734
26. Ip WK, Lau YL, Chan SY, Mok CC, Chan D, Tong KK, Lau CS (2000) Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arthr Rheum 43:1679-1687
27. Saevarsdottir S, Ding B, Steinsson K, Grondal G, Valdimarsson H, Alfredsson L et al (2011) Mannan binding lectin (MBL) genotypes coding for high MBL serum levels are associated with rheumatoid factor negative rheumatoid arthritis in never smokers. Arthr Res Ther 13:R65
28. Horiuchi T, Tsukamoto H, Morita C, Sawabe T, Harashima S, Nakashima H et al (2000) Mannose binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese. Genes Immun 1:464-466
29. van de Geijn FE, Hazes JM, Geleijns K, Emonts M, Jacobs BC, Dufour-van den Goorbergh BC, Dolhain RJ (2008) Mannose-binding lectin polymorphisms are not associated with rheumatoid arthritis-confirmation in two large cohorts. Rheumatology 47:1168-1171
30. van de Geijn FE, de Man YA, Wuhrer M, Willemsen SP, Deelder AM, Hazes JM, Dolhain RJ (2011) Mannose-binding lectin does not explain the course and outcome of pregnancy in rheumatoid arthritis. Arthr Res Ther 13:R10
31. Kallberg H, Padyukov L, Plenge RM, Ronnelid J, Gregersen PK, van der Helm-van Mil AH (2007) Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 80:867-875
32. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L (2004) A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthr Rheum 50:3085-3092
33. Troelsen LN, Jacobsen S, Abrahams JL, Royle L, Rudd PM, Narvestad E et al (2012) IgG glycosylation changes and MBL2 polymorphisms: associations with markers of systemic inflammation and joint destruction in rheumatoid arthritis. J Rheumatol 39:463-469
34. Arnold JN, Wormald MR, Suter DM, Radcliffe CM, Harvey DJ, Dwek RA et al (2005) Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin. J Biol Chem 280:29080-29087
35. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1:237-243
36. Saevarsdottir S, Steinsson K, Ludviksson BR, Grondal G, Valdimarsson H (2007) Mannan-binding lectin may facilitate the clearance of circulating immune complexes-implications from a study on C2-deficient individuals. Clin Exp Immunol 148:248-253
37. Gupta B, Raghav SK, Das HR (2008) S-nitrosylation of mannose binding lectin regulates its functional activities and the formation of autoantibody in rheumatoid arthritis. Nitric Oxide 18:266-273
38. Maffei G, Brouwer N, Dolman KM, van der Velden U, Roos D, Loos BG (2005) Plasma levels of mannan-binding lectin in relation to periodontitis and smoking. J Periodontol 76:1881-1889
39. Hoegh SV, Lindegaard HM, Sorensen GL, Høj A, Bendixen C, Junker P, Holmskov U (2008) Circulating surfactant protein D is decreased in early rheumatoid arthritis: a 1-year prospective study. Scand J Immunol 67:71-76
40. Taniguchi K, Usui Y, Matsuda T, Suzuki S, Fujiki K, Yakusiji F et al (2005) Methotrexate-induced acute lung injury in a patient with rheumatoid arthritis. Int J Clin Pharmacol Res 25:101-105
41. Yoshida M, Korfhagen TR, Whitsett JA (2001) Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J Immunol 166:7514-7519
42. Yoshida M, Whitsett JA (2006) Alveolar macrophages and emphysema in surfactant protein-D-deficient mice. Respirology 11(Suppl):S37-S40
43. Casey J, Kaplan J, Atochina-Vasserman EN, Gow AJ, Kadire H, Tomer Y et al (2005) Alveolar surfactant protein D content modulates bleomycin-induced lung injury. Am J Respir Crit Care Med 172:869-877
44. Betsuyaku T, Kuroki Y, Nagai K, Nasuhara Y, Nishimura M (2004) Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid. Eur Respir J 24:964-970
45. Kankavi O, Roberts MS (2004) Detection of surfactant protein A (SP-A) and surfactant protein D (SP-D) in equine synovial fluid with immunoblotting. Can J Vet Res 68:146-149
46. Kankavi O (2006) Increased expression of surfactant protein A and D in rheumatoid arthritic synovial fluid (RASF). Croat Med J 47:155-161
47. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, Henson PM (2003) By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115:13-23
48. Guo CJ, Atochina-Vasserman EN, Abramova E, Foley JP, Zaman A, Crouch E et al (2008) S-nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol 6:e266
49. Schett G, Zwerina J, Firestein G (2008) The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis. Ann Rheum Dis 67:909-916